The effect of Hetastarch (670/0.75) in vivo on platelet closure time in the dog

Journal of Veterinary Emergency and Critical Care

Volumn 19, Issue 5, 2009, Pages 444-449

  Smart, Lisa ^a,b,c   Jandrey, Karl E ^a,b,c   Kass, Philip H ^a,b,c   Wierenga, Janelle R ^a,b,c   Tablin, Fern ^a,b,c  

^a MURDOCH UNIVERSITY   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c American College of Veterinary Internal Medicine Forum   (United States)

Author keywords

Artificial colloid; Canine; Closure time; Coagulopathy; Hydroxyethyl starch

Indexed keywords

HETASTARCH;

ANIMAL; ARTICLE; BLOOD; DOG; DRUG EFFECT; FEMALE; MALE; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; DOGS; FEMALE; HETASTARCH; MALE;

ANIMALIA; CANIS FAMILIARIS;

EID: 70350474749     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2009.00464.x     Document Type: Article

References (37)

1. Treib J, Baron JF, Grauer MT, et al. An international view of hydroxyethyl starches. Intensive Care Med 1999 25 : 258 268.
2. Treib J, Haass A, Pindur G. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 1997 78 : 974 983.
3. Deusch E, Thaler U, Kozek-Langenecker SA. The effects of high molecular weight hydroxyethyl starch solutions on platelets. Anesth Analg 2004 99 : 665 668.
4. Deusch E, Gamsjäger T, Kress HG, et al. Binding of hydroxyethyl starch molecules to the platelet surface. Anesth Analg 2003 97 : 680 683.
5. Jamnicki M, Zollinger A, Seifert B, et al. Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thromboelastography. Anesth Analg 1998 87 : 989 993.
6. Stögermüller B, Stark J, Willschke H, et al. The effect of hydroxyethyl starch 200 kD on platelet function. Anesth Analg 2000 91 : 823 827.
7. Franz A, Bräunlich P, Gamsjäger T, et al. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001 92 : 1402 1407.
8. Scharbert G, Deusch E, Kress HG, et al. Inhibition of platelet function by hydroxyethyl starch solutions in chronic pain patients undergoing peridural anesthesia. Anesth Analg 2004 99 : 823 827.
9. Innerhofer P, Fries D, Margreiter J, et al. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 2002 95 : 858 865.
10. Jamnicki M, Bombeli T, Seifert B, et al. Low- and medium-molecular-weight hydroxyethyl starches - comparison of their effect on blood coagulation. Anesthesiology 2000 93 (5) : 1231 1237.
11. ®) on measures of coagulation. Br J Anaes 2002 89 (5) : 722 728.
12. Kuitunen AH, Hynyen MJ, Vahtera E, et al. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg 2004 98 : 291 297.
13. Boldt J, Knothe C, Zickman B, et al. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesth Analg 1993 76 (6) : 1185 1190.
14. Macintyre E, Mackie IJ, Ho D, et al. The haemostatic effects of hydroxyethyl starch (HES) used as a volume expander. Intensive Care Med 1985 11 : 300 303.
15. Hüttner I, Boldt J, Haisch G, et al. Influence of different colloids on molecular markers of haemostasis and platelet function in patients undergoing major abdominal surgery. Br J Anaes 2000 85 (3) : 417 423.
16. Francis JL. The platelet function analyzer (PFA) - 100, In : Michelson AD. ed. Platelets, 2nd edn. St Louis : Elsevier Inc 2007, pp. 519 534.
17. Trumble ER, Muizelaar JP, Myseros JS, et al. Coagulopathy with the use of hetastarch in the treatment of vasospasm. J Neurosurg 1995 82 : 44 47.
18. Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005 103 (3) : 654 660.
19. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg 2001 72 (2) : 527 533.
20. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, et al. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 2008 107 (2) : 382 390.
21. Wierenga JR, Jandrey KE, Haskins SC, et al. In vitro comparison of the effects of two forms of hydroxyethyl starch solutions on platelet function in dogs. Am J Vet Res 2007 68 (6) : 605 609.
22. Callan M, Giger U. Assessment of a point-of-care instrument for identification of primary hemostatic disorders in dogs. Am J Vet Res 2001 62 (5) : 652 658.
23. Holm S. A simple sequentially rejective multiple test procedure. Scand Stat Theory Appl 1979 6 : 65 70.
24. ® (hydroxyethyl starch 130/0.4) or hetastarch. Anesthesiology 2007 106 (6) : 1120 1127.
25. Treib J, Haass A, Pindur G, et al. Highly substituted hydroxyethyl starch (HES 200/0.62) leads to Type-1 von Willebrand syndrome after repeated administration. Haemostasis 1996 26 (4) : 210 213.
26. Nichols WC, Cooney KA, Ginsburg D, et al. von Willebrand disease, In : Loscalzo J, Schafer AI. eds. Thrombosis and Hemorrhage, 3rd edn. Philadelphia : Lippincott Williams and Wilkins 2003, 539pp.
27. Conroy JM, Fishman RL, Reeves ST, et al. The effects of desmopressin and 6% hydroxyethyl starch on factor VIII:C. Anesth Analg 1996 83 : 804 807.
28. Stoll M, Treib J, Schenk JF, et al. No coagulation disorders under high-dose volume therapy with low-molecular-weight hydroxyethyl starch. Haemostasis 1997 27 (5) : 251 258.
29. Yacobi A, Gibson TP, McEntegart CM, et al. Pharmacokinetics of high molecular weight hydroxyethyl starch in dogs. Res Commun Chem Pathol Pharmacol 1982 36 (2) : 199 204.
30. Yacobi A, Stoll RG, Sum CY, et al. Pharmacokinetics of hydroxyethyl starch in normal subjects. J Clin Pharmacol 1982 22 : 206 212.
31. Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005 44 (7) : 681 699.
32. (R) in testing abnormalities of primary hemostasis. Blood Coagul Fibrinolysis 1999 10 (1) : 25 32.
33. ™. Clin Appl Thromb Hemost 1996 2 (4) : 241 249.
34. Keidel A, Mischke R. Clinical evaluation of platelet function analyzer PFA-100 in dogs (in German). Berl Munch Tierarztl Wochenschr 1998 111 (11-12) : 452 456. (Pubitemid 128539824)
35. Mischke R, Keidel Influence of platelet count, acetylsalicylic acid, von Willebrand's disease, coagulopathies, and haematocrit on results obtained using a platelet function analyser in dogs. Vet J 2003 165 : 43 52.
36. Singbartl K, Innerhofer P, Radvan J, et al. Hemostasis and hemodilution: a quantitative mathematical guide for clinical practice. Anesth Analg 2003 96 : 929 935.
37. Silverstein DC, Aldrich J, Haskins SC, et al. Assessment of changes in blood volume in response to resuscitative fluid administration in dogs. J Vet Emerg Crit Care 2005 15 (3) : 185 192.